Free Trial

Medpace (MEDP) Earnings Date, Estimates & Call Transcripts

Medpace logo
$326.09 +11.13 (+3.53%)
(As of 11/20/2024 ET)

Medpace Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 10Estimated
Actual EPS
(Oct. 21)
$3.01 Beat By $0.24
Consensus EPS
(Oct. 21)
$2.77

Medpace issued Q3 2024 earnings on October 21, 2024, reporting an EPS of $3.01, which topped analysts' consensus estimates of $2.77 by $0.24. Quarterly revenue rose 8.3% year-over-year to $533.32 million, below the consensus estimate of $540.99 million. With a trailing EPS of $11.42 and a P/E Ratio of 28.55, Medpace's earnings are expected to grow 3.27% next year, from $11.93 to $12.32 per share.

MEDP Upcoming Earnings

Medpace's next earnings date is estimated for Monday, February 10, 2025, based off prior year's reporting schedules.

Get Medpace Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medpace and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MEDP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MEDP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Medpace Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$2.08$2.45$2.27 
Q2 20242$2.01$2.49$2.25 
Q3 20242$2.28$2.74$2.51 
Q4 20242$2.56$2.87$2.72 
FY 20248$8.93$10.55$9.74 
Q1 20251$2.92$2.92$2.92 
Q2 20251$3.06$3.06$3.06 
Q3 20251$3.18$3.18$3.18 
Q4 20251$3.19$3.19$3.19 
FY 20254$12.35$12.35 $12.35

Medpace Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/10/2025
(Estimated)
------- 
10/21/2024Q3 2024$2.77$3.01+$0.24$3.01$540.99M$533.32M          
7/22/2024Q2 2024$2.54$2.75+$0.21$2.75$528.41M$528.10M          
4/22/2024Q1 2024$2.45$3.20+$0.75$3.20$512.39M$511.00M        
2/12/2024Q4 2023$2.22$2.46+$0.24$2.46$498.72M$498.40M        
10/23/2023Q3 2023$2.05$2.22+$0.17$2.22$475.79M$492.50M        
7/24/2023Q2 2023$1.90$1.93+$0.03$1.93$433.75M$460.90M        
4/24/2023Q1 2023$1.76$2.27+$0.51$2.27$402.83M$434.07M        
2/13/2023Q4 2022$1.78$2.12+$0.34$2.12$386.09M$394.10M        

Medpace Earnings - Frequently Asked Questions

Medpace has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 10th, 2025 based off last year's report dates. Learn more on MEDP's earnings history.

Medpace updated its FY 2024 earnings guidance on Monday, October, 21st. The company provided EPS guidance of 11.710-12.090 for the period, compared to the consensus EPS estimate of 11.560. The company issued revenue guidance of $2.1 billion-$2.1 billion, compared to the consensus revenue estimate of $2.1 billion.

In the previous quarter, Medpace (NASDAQ:MEDP) reported $3.01 earnings per share (EPS) to beat the analysts' consensus estimate of $2.77 by $0.24. Learn more on analysts' earnings estimate vs. MEDP's actual earnings.

The conference call for Medpace's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Medpace's latest earnings report can be read online.
Read Transcript

Medpace's earnings report can be found in their filing with the SEC.
View SEC filing

Medpace (NASDAQ:MEDP) has a recorded annual revenue of $1.89 billion.

Medpace (NASDAQ:MEDP) has a recorded net income of $282.81 million. MEDP has generated $11.42 earnings per share over the last four quarters.

Medpace (NASDAQ:MEDP) has a trailing price-to-earnings ratio of 28.55 and a forward price-to-earnings ratio of 27.33. The price/earnings-to-growth ratio is 1.72.

Medpace's earnings are expected to grow from $11.93 per share to $12.32 per share in the next year, which is a 3.27% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:MEDP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners